PITUITARY GLAND Can prolactinomas be cured medically?

被引：9

作者：

Molitch, Mark E. ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

NATURE REVIEWS ENDOCRINOLOGY | 2010年 / 6卷 / 04期

关键词：

TERM CABERGOLINE THERAPY; DOPAMINE AGONISTS; HYPERPROLACTINEMIA; WITHDRAWAL; BROMOCRIPTINE; ADENOMAS;

D O I：

10.1038/nrendo.2009.278

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

A systematic review and meta-analysis by Dekkers et al. has assessed the effects of dopamine agonist withdrawal in patients with hyperprolactinemia. But not all dopamine agonists are the same, and much depends on the criteria for patient selection and the drug withdrawal strategy.

引用

页码：186 / 188

页数：4

共 10 条

[1]

Dopamine as a prolactin (PRL) inhibitor [J].

Ben-Jonathan, N ;

Hnasko, R .

ENDOCRINE REVIEWS, 2001, 22 (06) :724-763

[2]

Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia [J].

Colao, A ;

Di Sarno, A ;

Cappabianca, P ;

Di Somma, C ;

Pivonello, R ;

Lombardi, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :2023-2033

[3]

Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy [J].

Colao, Annamaria ;

Di Sarno, Antonella ;

Guerra, Ermelinda ;

Pivonello, Rosario ;

Cappabianca, Paolo ;

Caranci, Ferdinando ;

Elefante, Andrea ;

Cavallo, Luigi M. ;

Briganti, Francesco ;

Cirillo, Sossio ;

Lombardi, Gaetano .

CLINICAL ENDOCRINOLOGY, 2007, 67 (03) :426-433

[4]

Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis [J].

Dekkers, Olaf M. ;

Lagro, Joep ;

Burman, Pia ;

Jorgensen, Jens Otto ;

Romijn, Johannes A. ;

Pereira, Alberto M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) :43-51

[5]

EFFECT OF BROMOCRIPTINE TREATMENT ON THE FIBROUS TISSUE CONTENT OF PROLACTIN-SECRETING AND NONFUNCTIONING MACROADENOMAS OF THE PITUITARY-GLAND [J].

ESIRI, MM ;

BEVAN, JS ;

BURKE, CW ;

ADAMS, CBT .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (02) :383-388

[6]

Advances in the treatment of prolactinomas [J].

Gillam, Mary P. ;

Molitch, Mark E. ;

Lombardi, Gaetano ;

Colao, Annamaria .

ENDOCRINE REVIEWS, 2006, 27 (05) :485-534

[7]

Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline Therapy [J].

Kharlip, J. ;

Salvatori, R. ;

Yenokyan, G. ;

Wand, G. S. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07) :2428-2436

[8]

Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists [J].

Kontogeorgos, G ;

Horvath, E ;

Kovacs, K ;

Coire, C ;

Lloyd, RV ;

Scheithauer, BW ;

Smyth, HS .

ACTA NEUROPATHOLOGICA, 2006, 111 (01) :46-52

[9]

PERIVASCULAR FIBROSIS IN PROLACTINOMAS - IS IT INCREASED BY BROMOCRIPTINE [J].

LANDOLT, AM ;

OSTERWALDER, V .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (06) :1179-1183

[10]

Effect of dopamine agonists on lactotroph adenomas of the human pituitary [J].

Stefaneanu, L ;

Kovacs, K ;

Scheithauer, BW ;

Kontogeorgos, G ;

Riehle, DL ;

Sebo, TJ ;

Murray, D ;

Vidal, S ;

Tran, A ;

Buchfelder, M ;

Fahlbusch, R .

ENDOCRINE PATHOLOGY, 2000, 11 (04) :341-352

← 1 →